{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T08:42:05Z","timestamp":1792399325450,"version":"4.4.0"},"reference-count":10,"publisher":"American Association for the Advancement of Science (AAAS)","funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2025-00562854"],"award-info":[{"award-number":["RS-2025-00562854"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["NRF-2023R1A2C2004339"],"award-info":[{"award-number":["NRF-2023R1A2C2004339"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2024-00438843"],"award-info":[{"award-number":["RS-2024-00438843"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["spj.science.org"],"crossmark-restriction":true},"short-container-title":["Cancer Commun"],"published-print":{"date-parts":[[2026,1,1]]},"DOI":"10.34133\/cancomm.0059","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:34:44Z","timestamp":1790685284000},"update-policy":"https:\/\/doi.org\/10.34133\/aaas_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["CAPTYN, a Blood-Based Machine-Learning Model Predicting Clinical Benefit of Atezolizumab\u2013Bevacizumab in Hepatocellular Carcinoma: Validation in the IMbrave150 Trial"],"prefix":"10.34133","volume":"46","author":[{"given":"Gae Hoon","family":"Jo","sequence":"first","affiliation":[{"name":"Department of Life Science, Graduate School, \rCHA University, Seongnam, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohyun","family":"Hwang","sequence":"additional","affiliation":[{"name":"Department of Pathology, CHA Bundang Medical Center, \rCHA University School of Medicine, Seongnam, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Scheiner","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine III, \rMedical University of Vienna, Vienna, Austria."},{"name":"Vienna Liver Cancer Study Group, Division of Gastroenterology and Hepatology, Department of Medicine III, \rMedical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seonjeong","family":"Woo","sequence":"additional","affiliation":[{"name":"Department of Life Science, Graduate School, \rCHA University, Seongnam, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Suk","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, CHA Bundang Medical Center, \rCHA University School of Medicine, Seongnam, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beodeul","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, CHA Bundang Medical Center, \rCHA University School of Medicine, Seongnam, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Sun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, CHA Bundang Medical Center, \rCHA University School of Medicine, Seongnam, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Yeong","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, CHA Bundang Medical Center, \rCHA University School of Medicine, Seongnam, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chansik","family":"An","sequence":"additional","affiliation":[{"name":"Department of Radiology, CHA Bundang Medical Center, \rCHA University School of Medicine, Seongnam, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Yun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, \rYonsei University College of Medicine, Seoul, Republic of Korea."},{"name":"Yonsei Liver Center, \rSeverance Hospital, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inyoung","family":"Kim","sequence":"additional","affiliation":[{"name":"Theragen Bio Co., Ltd.","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-hyuk","family":"Heo","sequence":"additional","affiliation":[{"name":"Theragen Bio Co., Ltd.","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Pinter","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine III, \rMedical University of Vienna, Vienna, Austria."},{"name":"Vienna Liver Cancer Study Group, Division of Gastroenterology and Hepatology, Department of Medicine III, \rMedical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Kyung","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, \rYonsei University College of Medicine, Seoul, Republic of Korea."},{"name":"Yonsei Liver Center, \rSeverance Hospital, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Graduate School of Medical Science, Brain Korea 21 Project, \rYonsei University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Jae","family":"Chon","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, CHA Bundang Medical Center, \rCHA University School of Medicine, Seongnam, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.3350\/cmh.2024.0824","article-title":"Hepatocellular carcinoma: Updates on epidemiology, surveillance, diagnosis and treatment","volume":"31","author":"Hwang SY","year":"2025","unstructured":"Hwang SY, Danpanichkul P, Agopian V, Mehta N, Parikh ND, Abou-Alfa GK, Singal AG, Yang JD. Hepatocellular carcinoma: Updates on epidemiology, surveillance, diagnosis and treatment. Clin Mol Hepatol. 2025;31(Suppl):S228\u2013S254.","journal-title":"Clin Mol Hepatol"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915745"},{"issue":"4","key":"e_1_3_4_4_2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3350\/cmh.2024.0333","article-title":"Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial","volume":"30","author":"Yim SY","year":"2024","unstructured":"Yim SY, Lee SH, Baek S-W, Sohn B, Jeong YS, Kang S-H, Park K, Park H, Lee SS, Kaseb AO, et al. Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial. Clin Mol Hepatol. 2024;30(4):807\u2013823.","journal-title":"Clin Mol Hepatol"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.09.035"},{"issue":"2","key":"e_1_3_4_6_2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000488778","article-title":"Validation of modified ALBI grade for more detailed assessment of hepatic function in hepatocellular carcinoma patients: A multicenter analysis","volume":"8","author":"Hiraoka A","year":"2019","unstructured":"Hiraoka A, Kumada T, Tsuji K, Takaguchi K, Itobayashi E, Kariyama K, Ochi H, Tajiri K, Hirooka M, Shimada N, et al. Validation of modified ALBI grade for more detailed assessment of hepatic function in hepatocellular carcinoma patients: A multicenter analysis. Liver Cancer. 2019;8(2):121\u2013129.","journal-title":"Liver Cancer"},{"issue":"5","key":"e_1_3_4_7_2","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/HEP.0000000000001444","article-title":"Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab\u2013bevacizumab","volume":"83","author":"Nam H","year":"2026","unstructured":"Nam H, Kim DY, Kim DY, Kim JH, Kim CW, Lee J, Yang K, Han JW, Sung PS, Yoon SK, et al. Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab\u2013bevacizumab. Hepatology. 2026;83(5):1098\u20131110.","journal-title":"Hepatology"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14133213"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01868-2"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2018.29"},{"issue":"1","key":"e_1_3_4_11_2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3350\/cmh.2025.0792","article-title":"Integrative multi-omics profiling identifies infiltrative hepatocellular carcinoma as an immunotherapy-resistant subtype with distinct molecular features","volume":"32","author":"Lee WS","year":"2026","unstructured":"Lee WS, Woo S, Lee SH, Jo GH, Kim I, Kim H, An C, Jung S, Kim G, Kang H, et al. Integrative multi-omics profiling identifies infiltrative hepatocellular carcinoma as an immunotherapy-resistant subtype with distinct molecular features. Clin Mol Hepatol. 2026;32(1):258\u2013275.","journal-title":"Clin Mol Hepatol"}],"container-title":["Cancer Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.34133\/cancomm.0059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T08:02:54Z","timestamp":1792396974000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.34133\/cancomm.0059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":10,"alternative-id":["10.34133\/cancomm.0059"],"URL":"https:\/\/doi.org\/10.34133\/cancomm.0059","relation":{},"ISSN":["2523-3548"],"issn-type":[{"value":"2523-3548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"assertion":[{"value":"2026-05-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"0059"}}